» Articles » PMID: 23645137

Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders

Overview
Date 2013 May 7
PMID 23645137
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

There is extensive bi-directional communication between the brain and the immune system in both health and disease. In recent years, the role of an altered immune system in the etiology of major psychiatric disorders has become more apparent. Studies have demonstrated that some patients with major psychiatric disorders exhibit characteristic signs of immune dysregulation and that this may be a common pathophysiological mechanism that underlies the development and progression of these disorders. Furthermore, many psychiatric disorders are also often accompanied by chronic medical conditions related to immune dysfunction such as autoimmune diseases, diabetes and atherosclerosis. One of the major psychiatric disorders that has been associated with an altered immune system is schizophrenia, with approximately one third of patients with this disorder showing immunological abnormalities such as an altered cytokine profile in serum and cerebrospinal fluid. An altered cytokine profile is also found in a proportion of patients with major depressive disorder and is thought to be potentially related to the pathophysiology of this disorder. Emerging evidence suggests that altered immune parameters may also be implicated in the neurobiological etiology of autism spectrum disorders. Further support for a role of immune dysregulation in the pathophysiology of these psychiatric disorders comes from studies showing the immunomodulating effects of antipsychotics and antidepressants, and the mood altering effects of anti-inflammatory therapies. This review will not attempt to discuss all of the psychiatric disorders that have been associated with an augmented immune system, but will instead focus on several key disorders where dysregulation of this system has been implicated in their pathophysiology including depression, schizophrenia and autism spectrum disorder.

Citing Articles

Nano-chitosan hydrogel alleviates Candida albicans-induced health alterations in Nile tilapia (Oreochromis niloticus): antioxidant response, neuro-behaviors, hepato-renal functions, and histopathological investigation.

Mahboub H, Rahman A, Elazab S, Abdelwarith A, Younis E, Shaalan M BMC Vet Res. 2025; 21(1):159.

PMID: 40057767 PMC: 11889809. DOI: 10.1186/s12917-025-04568-4.


Deep immunophenotyping of circulating immune cells in major depressive disorder patients reveals immune correlates of clinical course and treatment response.

Stolfi F, Brasso C, Raineri D, Landra V, Mazzucca C, Ghazanfar A Brain Behav Immun Health. 2025; 43:100942.

PMID: 39877852 PMC: 11773243. DOI: 10.1016/j.bbih.2024.100942.


Exploring the Different Impacts of Ketamine on Neurotrophic Factors and Inflammatory Parameters in a Cecal Ligation and Puncture-Induced Sepsis Model.

Aguiar-Geraldo J, Canever L, Marino D, Coan C, Possamai-Della T, Pescador B Neurotox Res. 2025; 43(1):5.

PMID: 39833594 DOI: 10.1007/s12640-024-00727-x.


The Use of Nutraceutical and Pharmacological Strategies in Murine Models of Autism Spectrum Disorder.

Bonetti M, Borsani E, Bonomini F Cells. 2025; 13(24.

PMID: 39768128 PMC: 11675073. DOI: 10.3390/cells13242036.


Association of dietary inflammatory index and systemic inflammatory markers with mortality risk in depressed adults: a mediation analysis of NHANES data.

Tang M, Chang X, Zheng H, Zeng F, Zhang G, He M Front Nutr. 2024; 11:1472616.

PMID: 39723161 PMC: 11669309. DOI: 10.3389/fnut.2024.1472616.


References
1.
Weigelt K, Carvalho L, Drexhage R, Wijkhuijs A, de Wit H, van Beveren N . TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors. Brain Behav Immun. 2011; 25(6):1162-9. DOI: 10.1016/j.bbi.2011.03.006. View

2.
Vignau J, Costisella O, Canva V, Imbenotte M, Duhamel A, Lhermitte M . [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients]. Encephale. 2009; 35(5):477-83. DOI: 10.1016/j.encep.2007.09.007. View

3.
Morgan J, Chana G, Abramson I, Semendeferi K, Courchesne E, Everall I . Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism. Brain Res. 2012; 1456:72-81. DOI: 10.1016/j.brainres.2012.03.036. View

4.
Kupper N, Widdershoven J, Pedersen S . Cognitive/affective and somatic/affective symptom dimensions of depression are associated with current and future inflammation in heart failure patients. J Affect Disord. 2011; 136(3):567-76. DOI: 10.1016/j.jad.2011.10.029. View

5.
Salazar A, Gonzalez-Rivera B, Redus L, Parrott J, OConnor J . Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm Behav. 2012; 62(3):202-9. PMC: 3425718. DOI: 10.1016/j.yhbeh.2012.03.010. View